The International Workshop on Non-Hodgkin Lymphoma (iwNHL) is a high-level discussion forum for academic and research leaders in the field of lymphoma and related disorders. The iwNHL was established in 2001 in order to further our understanding of recent NHL advances in a workshop environment, to encourage interactive debate and discussion. The iwNHL Scientific Committee have targeted areas for discussion where new evidence, new insights, or novel therapies or approaches, have implications for clinical practice.

In the 2014 iwNHL meeting, controversies in Mantle Cell lymphoma will be discussed including a discussion on rational combination therapies. T cell lymphoma is also included in the programme, as this rare entity is not often discussed, and optimal treatment options are not well defined. New insights into the potential contribution of proteasome inhibitors and IMiDs to the treatment of NHL will be discussed. There will be a session on the biology and treatment of DLBCL and also a session on what lessons can be learned from myeloma biology and therapies and be applied to NHL today.

Also in this year’s iwNHL meeting, there will be a session focussing on recent emerging data and novel treatment options in lymphoma.